211 related articles for article (PubMed ID: 34180951)
21. The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.
Ajore R; Kumar P; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2012 Mar; 13():11. PubMed ID: 22443175
[TBL] [Abstract][Full Text] [Related]
22. Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b.
Zhou W; Gao F; Romero-Wolf M; Jo S; Rothenberg EV
Sci Immunol; 2022 May; 7(71):eabm1920. PubMed ID: 35594339
[TBL] [Abstract][Full Text] [Related]
23. Runx1 is essential at two stages of early murine B-cell development.
Niebuhr B; Kriebitzsch N; Fischer M; Behrens K; Günther T; Alawi M; Bergholz U; Müller U; Roscher S; Ziegler M; Buchholz F; Grundhoff A; Stocking C
Blood; 2013 Jul; 122(3):413-23. PubMed ID: 23704093
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
25. Pin1-mediated prolyl isomerization of Runx1 affects PU.1 expression in pre-monocytes.
Islam R; Yoon WJ; Woo KM; Baek JH; Ryoo HM
J Cell Physiol; 2014 Apr; 229(4):443-52. PubMed ID: 24037986
[TBL] [Abstract][Full Text] [Related]
26. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
[TBL] [Abstract][Full Text] [Related]
27. GATA-3 dose-dependent checkpoints in early T cell commitment.
Scripture-Adams DD; Damle SS; Li L; Elihu KJ; Qin S; Arias AM; Butler RR; Champhekar A; Zhang JA; Rothenberg EV
J Immunol; 2014 Oct; 193(7):3470-91. PubMed ID: 25172496
[TBL] [Abstract][Full Text] [Related]
28. The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.
Hoogenkamp M; Krysinska H; Ingram R; Huang G; Barlow R; Clarke D; Ebralidze A; Zhang P; Tagoh H; Cockerill PN; Tenen DG; Bonifer C
Mol Cell Biol; 2007 Nov; 27(21):7425-38. PubMed ID: 17785440
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development.
Rothenberg EV; Hosokawa H; Ungerbäck J
Front Immunol; 2019; 10():228. PubMed ID: 30842770
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
32. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
33. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
34. Gata3 targets Runx1 in the embryonic haematopoietic stem cell niche.
Fitch SR; Kapeni C; Tsitsopoulou A; Wilson NK; Göttgens B; de Bruijn MF; Ottersbach K
IUBMB Life; 2020 Jan; 72(1):45-52. PubMed ID: 31634421
[TBL] [Abstract][Full Text] [Related]
35. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes.
Telfer JC; Hedblom EE; Anderson MK; Laurent MN; Rothenberg EV
J Immunol; 2004 Apr; 172(7):4359-70. PubMed ID: 15034051
[TBL] [Abstract][Full Text] [Related]
36. Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.
Thompson PK; Chen ELY; de Pooter RF; Frelin C; Vogel WK; Lee CR; Venables T; Shah DK; Iscove NN; Leid M; Anderson MK; Zúñiga-Pflücker JC
J Immunol; 2022 Jul; 209(1):77-92. PubMed ID: 35705252
[TBL] [Abstract][Full Text] [Related]
37. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
[TBL] [Abstract][Full Text] [Related]
38. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.
Yu M; Mazor T; Huang H; Huang HT; Kathrein KL; Woo AJ; Chouinard CR; Labadorf A; Akie TE; Moran TB; Xie H; Zacharek S; Taniuchi I; Roeder RG; Kim CF; Zon LI; Fraenkel E; Cantor AB
Mol Cell; 2012 Feb; 45(3):330-43. PubMed ID: 22325351
[TBL] [Abstract][Full Text] [Related]
39. The RUNX1-PU.1 axis in the control of hematopoiesis.
Imperato MR; Cauchy P; Obier N; Bonifer C
Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
[TBL] [Abstract][Full Text] [Related]
40. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity.
Zhang JA; Mortazavi A; Williams BA; Wold BJ; Rothenberg EV
Cell; 2012 Apr; 149(2):467-82. PubMed ID: 22500808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
